Farallon Capital Management’s Oscar Health OSCR Stock Holding History

Farallon Capital Management’s Portfolio OSCR Stock Details OSCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-11,000	Closed	-$126K	–	158
2026 Q1	$126K	Sell	11,000 -253,000	-96%	-$3.56M	﹤0.01%	159
2025 Q4	$3.79M	Sell	264,000 -3,375,000	-93%	-$58.4M	0.02%	79
2025 Q3	$68.9M	Buy	3,639,000 +2,163,000	+147%	+$35.6M	0.28%	51
2025 Q2	$31.6M	Buy	1,476,000 +1,465,000	+13,318%	+$21.8M	0.13%	63
2025 Q1	$144K	Hold	11,000	–	–	﹤0.01%	128
2024 Q4	$148K	Hold	11,000	–	–	﹤0.01%	137
2024 Q3	$233K	Hold	11,000	–	–	﹤0.01%	134
2024 Q2	$174K	Hold	11,000	–	–	﹤0.01%	145
2024 Q1	$164K	Buy	+11,000	New	+$151K	﹤0.01%	152

Other funds holding OSCR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

TCMNY

Thrive Capital Management (New York) New York $3.81B AUM 45.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Farallon Capital Management's OSCR Position: Q2 2026 in Review

Farallon Capital Management sold out of Oscar Health (OSCR) in Q2 2026, closing a stake of 11,000 shares — an estimated $126K sold.

Farallon Capital Management first reported a position in OSCR in Q1 2024 and held it in 9 quarters. The position peaked at $68.9M in Q3 2025. 402 funds tracked by Wall St. Rank hold OSCR as of Q2 2026.

Farallon Capital Management reported no remaining Oscar Health position as of Q2 2026 after selling out during the quarter.
Farallon Capital Management sold 11,000 Oscar Health shares in Q2 2026, an estimated $126K.
Farallon Capital Management first reported a position in Oscar Health in Q1 2024 and held it in 9 quarters.
Farallon Capital Management's Oscar Health position peaked at $68.9M in Q3 2025.
402 funds tracked by Wall St. Rank held Oscar Health as of Q2 2026.

Based on Farallon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.